SUMOylation and Cell Sensitivity to Top1 Poisons
SUMO 化和细胞对 Top1 毒物的敏感性
基本信息
- 批准号:7087936
- 负责人:
- 金额:$ 28.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Eukaryotic DNA topoisomerase I (Top1p) plays important roles in DNA replication, transcription and recombination, and catalyzes changes in DNA topology through the transient breakage and rejoining of a single DNA strand in duplex DNA. Top1p is also the target of camptothecin (CRT), which reversibly stabilizes a covalent enzyme-DNA intermediate. During S-phase, replication fork collisions with CRT-stabilized complexes produce DNA lesions that signal cell cycle arrest and cell death. However, little is known about the nature of the lesions produced and the cellular processes that resolve Top1p-induced DNA damage. Post-translational protein modifications by ubiquitin and ubiquitin-like proteins (such as SUMO) have emerged as critical regulatory mechanisms governing cell cycle progression, DNA repair, endocytosis, nucleocytoplasmic trafficking, transcription, chromatin structure and cell division. SUMO is attached to target proteins via an isopeptide linkage by the sequential action of an E1, E2 (Ubc9) and, in some cases, E3 enzymes. Sumoylation of human Top1p has been associated with alterations in nucleolar localization and CRT sensitivity. However, the mechanisms regulating SUMO conjugation of Top1p and the functional consequences of sumoylation on cellular pathways required for the effective repair of DNA lesions induced by chemotherapeutic agents that target Top1p have yet to be addressed. The goal of this proposal is to define the role of Ubc9-catalyzed sumoylation in protecting cells from Top1p poisons in the yeast Saccharomyces cerevisiae. Highly conserved mechanisms of Top1p poisoning and SUMO conjugation, in concert with the isolation of a conditional ubc9-10 mutant with enhanced sensitivity to Top1p-induced damage, makes this genetically tractable system particularly suited to the study of sumoylation and Top1p-mediated lethality. Genetic interactions between the SUMO protease, Ulp2p and Top1p in maintaining genomic stability will also be investigated. To accomplish this, integrated biochemical, structural and genetics analyses will assess the defects in Ubc9p substrate specificity, reveal the structural basis for these alterations and define the cellular processes whose function in modulating resistance to Top1p poisons is affected by defects in SUMO conjugation. Human/yeast Ubc9p chimeras will further define residues that dictate substrate specificity. Additional studies will determine if similar mechanisms regulate ulp2Adelta cell sensitivity to Top1p levels and genomic stability.
描述(申请人提供):真核生物DNA拓扑异构酶I (Top1p)在DNA复制、转录和重组中发挥重要作用,通过双链DNA单链的瞬间断裂和重新连接来催化DNA拓扑结构的变化。Top1p也是喜树碱(CRT)的靶标,喜树碱可以可逆地稳定共价酶- dna中间体。在s期,复制叉与crt稳定的复合物碰撞产生DNA损伤,这是细胞周期停滞和细胞死亡的信号。然而,对于所产生的病变的性质和解决top1p诱导的DNA损伤的细胞过程知之甚少。泛素和泛素样蛋白(如SUMO)的翻译后蛋白修饰已成为控制细胞周期进程、DNA修复、内吞作用、核细胞质运输、转录、染色质结构和细胞分裂的关键调节机制。SUMO通过E1、E2 (Ubc9)和E3酶的顺序作用,通过异肽链连接到靶蛋白上。人类Top1p的sumo化与核仁定位和CRT敏感性的改变有关。然而,调节Top1p的SUMO偶联的机制以及SUMO化对有效修复由靶向Top1p的化疗药物诱导的DNA损伤所需的细胞通路的功能后果尚未得到解决。本提案的目的是确定ubc9催化的summoylation在酵母中保护细胞免受Top1p毒害的作用。Top1p中毒和SUMO偶联的高度保守机制,以及对Top1p诱导损伤敏感性增强的条件ubc9-10突变体的分离,使这个遗传上易于处理的系统特别适合于研究SUMO化和Top1p介导的致死率。SUMO蛋白酶、Ulp2p和Top1p在维持基因组稳定性方面的遗传相互作用也将被研究。为了实现这一目标,综合生化、结构和遗传学分析将评估Ubc9p底物特异性的缺陷,揭示这些改变的结构基础,并定义SUMO偶联缺陷影响调节对Top1p毒物抗性的细胞过程。人/酵母Ubc9p嵌合体将进一步确定决定底物特异性的残基。进一步的研究将确定是否有类似的机制调节ulp2Adelta细胞对Top1p水平的敏感性和基因组稳定性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY-ANN BJORNSTI其他文献
MARY-ANN BJORNSTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY-ANN BJORNSTI', 18)}}的其他基金
2014 DNA Topoisomerases in Biology and Medicine Gordon Research Conference
2014 DNA 拓扑异构酶在生物学和医学戈登研究会议
- 批准号:
8714782 - 财政年份:2014
- 资助金额:
$ 28.93万 - 项目类别:
SUMOylation and Cell Sensitivity to Top1 Poisons
SUMO 化和细胞对 Top1 毒物的敏感性
- 批准号:
7225898 - 财政年份:2005
- 资助金额:
$ 28.93万 - 项目类别:
相似国自然基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
- 批准号:QN25H220002
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
- 批准号:TGY24H080011
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
- 批准号:82305053
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向Cell-Free网络的协同虚拟化与动态传输
- 批准号:62371367
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
- 批准号:82373069
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
- 批准号:82273886
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
- 批准号:2021JJ30609
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Mass spectrometric system with single-cell-sensitivity for quantitative proteomics
用于定量蛋白质组学的具有单细胞灵敏度的质谱系统
- 批准号:
518551069 - 财政年份:2023
- 资助金额:
$ 28.93万 - 项目类别:
Major Research Instrumentation
Quantifying replication dynamics to predict clonal evolution and drug sensitivity in cancer cells using single-cell whole genome sequencing
使用单细胞全基因组测序量化复制动态以预测癌细胞的克隆进化和药物敏感性
- 批准号:
10603140 - 财政年份:2023
- 资助金额:
$ 28.93万 - 项目类别:
TempO-LINC high throughput high sensitivity single cell gene expression profiling assay Ph II
TempO-LINC 高通量高灵敏度单细胞基因表达谱分析第二阶段
- 批准号:
10699784 - 财政年份:2023
- 资助金额:
$ 28.93万 - 项目类别:
The SIK2 Inhibitor GRN-300 Enhances PARP Inhibitor Sensitivity and Cytotoxic T-Cell Function in Ovarian Cancer
SIK2 抑制剂 GRN-300 增强卵巢癌中 PARP 抑制剂的敏感性和细胞毒性 T 细胞功能
- 批准号:
10709229 - 财政年份:2023
- 资助金额:
$ 28.93万 - 项目类别:
Elucidation of the molecular mechanism of olfactory ultra sensitivity and their reconstruction by using cell-integrated approach
嗅觉超敏分子机制的阐明及其细胞整合方法的重建
- 批准号:
23H00244 - 财政年份:2023
- 资助金额:
$ 28.93万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
High-sensitivity micro analysis of woody plant cell wall lignins by 13C labeling and non-thermal microdissection
通过 13C 标记和非热显微切割对木本植物细胞壁木质素进行高灵敏度微分析
- 批准号:
23H02275 - 财政年份:2023
- 资助金额:
$ 28.93万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The mechanistic underpinnings of anabolic sensitivity to dietary protein in older adults: a combined non-invasive in vivo and cell-based ex vivo approach
老年人对膳食蛋白质合成代谢敏感性的机制基础:非侵入性体内和基于细胞的离体方法相结合
- 批准号:
471941 - 财政年份:2022
- 资助金额:
$ 28.93万 - 项目类别:
Fellowship Programs
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
胰腺癌恶性细胞状态的基质调节和治疗敏感性
- 批准号:
10517569 - 财政年份:2022
- 资助金额:
$ 28.93万 - 项目类别:
Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers
使用代谢成像和循环肿瘤细胞 (CTC) 生物标志物量化顺铂敏感性和耐药性
- 批准号:
10518179 - 财政年份:2022
- 资助金额:
$ 28.93万 - 项目类别:
Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers
使用代谢成像和循环肿瘤细胞 (CTC) 生物标志物量化顺铂敏感性和耐药性
- 批准号:
10707179 - 财政年份:2022
- 资助金额:
$ 28.93万 - 项目类别:














{{item.name}}会员




